Relative Bioavailability of LY03010 Compared to Listed Drug

Clinical trial NCT04922593 · COMPLETED

Trial details

NCT number: NCT04922593
Sponsor: Luye Pharma Group Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Psychotic Disorders Mood Disorders Schizophrenia Spectrum Mental Disorders Antipsychotic Agents Tranquilizing Agents Central Nervous System Depressants Physiological Effects of Drugs Psychotropic Drugs Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action

Start date: 2021-01-13
Primary completion: 2022-03-15
Enrollment: 281

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.